Cargando…
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Backgrounds: The relationship between sarcopenia, characterized by loss of muscle mass and strength, and survival outcomes of esophageal cancer is controversial. This study aimed to assess the effect of sarcopenia and skeletal muscle loss on overall survival (OS) and recurrence-free survival (RFS) o...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226603/ https://www.ncbi.nlm.nih.gov/pubmed/32290037 http://dx.doi.org/10.3390/cancers12040925 |
_version_ | 1783534327431168000 |
---|---|
author | Yoon, Han Gyul Oh, Dongryul Ahn, Yong Chan Noh, Jae Myoung Pyo, Hongryull Cho, Won Kyung Song, Yun Mi Park, Minsu Hwang, Na Young Sun, Jong-Mu Kim, Hong Kwan Zo, Jae Ill Shim, Young Mog |
author_facet | Yoon, Han Gyul Oh, Dongryul Ahn, Yong Chan Noh, Jae Myoung Pyo, Hongryull Cho, Won Kyung Song, Yun Mi Park, Minsu Hwang, Na Young Sun, Jong-Mu Kim, Hong Kwan Zo, Jae Ill Shim, Young Mog |
author_sort | Yoon, Han Gyul |
collection | PubMed |
description | Backgrounds: The relationship between sarcopenia, characterized by loss of muscle mass and strength, and survival outcomes of esophageal cancer is controversial. This study aimed to assess the effect of sarcopenia and skeletal muscle loss on overall survival (OS) and recurrence-free survival (RFS) of esophageal cancer patients. Methods: We retrospectively collected the medical records of 248 male patients diagnosed with squamous cell esophageal cancer and who underwent neoadjuvant chemoradiotherapy (NACRT) followed by surgery. We measured the cross-sectional area of the skeletal muscle at the L3 vertebra level using computed tomography images and calculated the skeletal muscle index (SMI). Sarcopenia was defined as SMI <52.4 cm(2)/m(2), and excessive muscle loss was defined as SMI change <−10.0%/50 days during NACRT. Moreover, laboratory test results, such as albumin, prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) before and after NACRT, were collected. Results: In the univariable Cox analysis, pre- (p = 0.689) and post-radiotherapy (RT) sarcopenia (p = 0.669) were not associated with OS. However, excessive muscle loss had a significant association with OS in both the univariable and multivariable analyses (all p = 0.001). Excessive muscle loss was also related to RFS in both the univariable (p = 0.011) and multivariable (p = 0.022) Cox analysis. Patients with excessive muscle loss had significantly lower levels of post-RT albumin (p < 0.001) and PNI (p < 0.001), higher levels of post-RT NLR (p = 0.031) and PLR (p = 0.071), larger decrease in albumin (p < 0.001) and PNI (p < 0.001) after NACRT, and larger increase in NLR (p = 0.051) and PLR (p = 0.088) after NACRT than in those with non-excessive muscle loss. Conclusion: Excessive muscle loss rather than pre- and post-RT sarcopenia was a significant prognostic factor for OS and RFS, and it was also related to nutritional and inflammatory markers. |
format | Online Article Text |
id | pubmed-7226603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72266032020-05-18 Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer Yoon, Han Gyul Oh, Dongryul Ahn, Yong Chan Noh, Jae Myoung Pyo, Hongryull Cho, Won Kyung Song, Yun Mi Park, Minsu Hwang, Na Young Sun, Jong-Mu Kim, Hong Kwan Zo, Jae Ill Shim, Young Mog Cancers (Basel) Article Backgrounds: The relationship between sarcopenia, characterized by loss of muscle mass and strength, and survival outcomes of esophageal cancer is controversial. This study aimed to assess the effect of sarcopenia and skeletal muscle loss on overall survival (OS) and recurrence-free survival (RFS) of esophageal cancer patients. Methods: We retrospectively collected the medical records of 248 male patients diagnosed with squamous cell esophageal cancer and who underwent neoadjuvant chemoradiotherapy (NACRT) followed by surgery. We measured the cross-sectional area of the skeletal muscle at the L3 vertebra level using computed tomography images and calculated the skeletal muscle index (SMI). Sarcopenia was defined as SMI <52.4 cm(2)/m(2), and excessive muscle loss was defined as SMI change <−10.0%/50 days during NACRT. Moreover, laboratory test results, such as albumin, prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) before and after NACRT, were collected. Results: In the univariable Cox analysis, pre- (p = 0.689) and post-radiotherapy (RT) sarcopenia (p = 0.669) were not associated with OS. However, excessive muscle loss had a significant association with OS in both the univariable and multivariable analyses (all p = 0.001). Excessive muscle loss was also related to RFS in both the univariable (p = 0.011) and multivariable (p = 0.022) Cox analysis. Patients with excessive muscle loss had significantly lower levels of post-RT albumin (p < 0.001) and PNI (p < 0.001), higher levels of post-RT NLR (p = 0.031) and PLR (p = 0.071), larger decrease in albumin (p < 0.001) and PNI (p < 0.001) after NACRT, and larger increase in NLR (p = 0.051) and PLR (p = 0.088) after NACRT than in those with non-excessive muscle loss. Conclusion: Excessive muscle loss rather than pre- and post-RT sarcopenia was a significant prognostic factor for OS and RFS, and it was also related to nutritional and inflammatory markers. MDPI 2020-04-10 /pmc/articles/PMC7226603/ /pubmed/32290037 http://dx.doi.org/10.3390/cancers12040925 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yoon, Han Gyul Oh, Dongryul Ahn, Yong Chan Noh, Jae Myoung Pyo, Hongryull Cho, Won Kyung Song, Yun Mi Park, Minsu Hwang, Na Young Sun, Jong-Mu Kim, Hong Kwan Zo, Jae Ill Shim, Young Mog Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer |
title | Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer |
title_full | Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer |
title_fullStr | Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer |
title_full_unstemmed | Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer |
title_short | Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer |
title_sort | prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226603/ https://www.ncbi.nlm.nih.gov/pubmed/32290037 http://dx.doi.org/10.3390/cancers12040925 |
work_keys_str_mv | AT yoonhangyul prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT ohdongryul prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT ahnyongchan prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT nohjaemyoung prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT pyohongryull prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT chowonkyung prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT songyunmi prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT parkminsu prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT hwangnayoung prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT sunjongmu prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT kimhongkwan prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT zojaeill prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer AT shimyoungmog prognosticimpactofsarcopeniaandskeletalmusclelossduringneoadjuvantchemoradiotherapyinesophagealcancer |